Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES)

Journal Title: Turkish Journal of Hematology - Year 2014, Vol 31, Issue 1

Abstract

Authors and Affiliations

Tülay Güler, Özden Çakmak, Selami Toprak, Seda Kibaroğlu, Ufuk Can

Keywords

Related Articles

The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Objective: Atypical chronic lymphocytic leukemia (CLL) is most frequently confused with mantle cell lymphoma (MCL). Several markers may contribute to the diagnosis of CLL. However, there is no consensus on which markers...

Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey

Hematopoietic stem cell transplantation is a promising curative therapy for many combined primary immunodeficiencies and phagocytic disorders. We retrospectively reviewed pediatric cases of patients diagnosed with primar...

Influence of Folate-Related Gene Polymorphisms on High-Dose Methotrexate-Related Toxicity and Prognosis in Turkish Children with Acute Lymphoblastic Leukemia

Objective: High-dose methotrexate (HD-MTX) is widely used in the consolidation phase of childhood acute lymphoblastic leukemia (ALL), but the roles that polymorphisms in folate-related genes (FRGs) play in HD-MTX toxicit...

Download PDF file
  • EP ID EP94901
  • DOI 10.4274/Tjh.2012.0191
  • Views 93
  • Downloads 0

How To Cite

Tülay Güler, Özden Çakmak, Selami Toprak, Seda Kibaroğlu, Ufuk Can (2014). Intrathecal Methotrexate-Induced Posterior Reversible Encephalopathy Syndrome (PRES). Turkish Journal of Hematology, 31(1), 109-110. https://europub.co.uk/articles/-A-94901